Lv2
135 积分 2023-07-03 加入
Gout
15天前
已完结
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
18天前
已完结
Immunogenicity of biologic therapies in psoriasis: Myths, facts and a suggested approach
1个月前
已完结
Effectiveness of Brodalumab for Guselkumab-Resistant Pustulotic Arthro-Osteitis in Patients With Palmoplantar Pustulosis: Case Series
2个月前
已完结
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab
2个月前
已完结
Age of onset matters: tildrakizumab response in early- vs. late-onset psoriasis
2个月前
已关闭
An overview of small-molecule agents for the treatment of psoriasis
3个月前
已完结
Systematic review of comparative studies on emerging psoriasis treatments: comparing biologics with biologics, small molecule inhibitors with small molecule inhibitors, and biologics with small molecule inhibitors
3个月前
已完结
Cost Dynamics of Biologic Switching for Psoriasis: A MarketScan Analysis
3个月前
已完结
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network
3个月前
已完结
皖公网安备34019202002308
